Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Medicinal research reviews (Print)

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/med.20120PMID 18271058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poly(ADP-Ribose) Polymerase Inhibitors

  2010cited by this paper
• Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice

  2008cited by this paper
• Mechanistic analysis of a suicide inactivator of histone demethylase LSD1.

  2007cited by this paper
• EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor

  2007cited by this paper
• HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics

  2007cited by this paper
• Epigenetic events in malignant melanoma.

  2007cited by this paper
• HDAC6 modulates cell motility by altering the acetylation level of cortactin.

  2007cited by this paper
• Development of histone deacetylase inhibitors for cancer treatment

  2007cited by this paper
• Histone acetyltransferase complexes: one size doesn't fit all

  2007cited by this paper
• Modification in reverse: the SUMO proteases.

  2007cited by this paper
• Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes

  2007cited by this paper
• Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase.

  2007cited by this paper
• Repair of alkylated DNA: recent advances.

  2007cited by this paper
• Pharmacological targeting of lysine acetyltransferases in human disease: a progress report.

  2007cited by this paper
• Epigenetics provides a new generation of oncogenes and tumour-suppressor genes.

  2007cited by this paper
• Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis.

  2007cited by this paper
• Specific inhibition of p300-HAT alters global gene expression and represses HIV replication.

  2007cited by this paper
• Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.

  2007cited by this paper
• Epigenetic regulation for the induction of meiosis

  2007cited by this paper
• Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression

  2007cited by this paper
• Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-κB and nuclear factor-κB–regulated gene products in IFN-α–sensitive and IFN-α–resistant human bladder cancer cells

  2007cited by this paper
• Small-molecule-mediated rescue of protein function by an inducible proteolytic shunt

  2007cited by this paper
• Histone deacetylase inhibitors for epigenetic therapy of cancer

  2007cited by this paper
• Cinnamoyl compounds as simple molecules that inhibit p300 histone acetyltransferase.

  2007cited by this paper
• HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions

  2007cited by this paper
• Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells.

  2007cited by this paper
• Small molecule modulators in epigenetics: implications in gene expression and therapeutics.

  2007cited by this paper
• Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.

  2007cited by this paper
• Histone modifications as markers of cancer prognosis: a cellular view

  2007cited by this paper
• 5-Aminoisoquinolin-1(2H)-one, a water-soluble poly (ADP-ribose) polymerase (PARP) inhibitor reduces the evolution of experimental periodontitis in rats.

  2007cited by this paper
• Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.

  2007cited by this paper
• JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor.

  2006influential reference
• Lysine residues in N-terminal and C-terminal regions of human histone H2A are targets for biotinylation by biotinidase.

  2006cited by this paper
• Methylation of tRNAAsp by the DNA Methyltransferase Homolog Dnmt2

  2006cited by this paper
• Discovery of two novel, small-molecule inhibitors of DNA methylation.

  2006cited by this paper
• Histone demethylation by a family of JmjC domain-containing proteins

  2006influential reference
• The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36

  2006cited by this paper
• A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.

  2006cited by this paper
• Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state.

  2006cited by this paper
• X-chromosome kiss and tell: how the Xs go their separate ways.

  2006cited by this paper
• Epigenetic therapy of cancer: past, present and future

  2006influential reference
• Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.

  2006cited by this paper
• Genome-wide location analysis: insights on transcriptional regulation.

  2006cited by this paper
• The molecular mechanism of HDAC inhibitors in anticancer effects.

  2006cited by this paper
• A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematologic Malignancies

  2006cited by this paper
• Role of epigenetic alterations in cholangiocarcinoma.

  2006cited by this paper
• Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.

  2006cited by this paper
• SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors.

  2006cited by this paper
• Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1.

  2006cited by this paper
• Alterations of histone modifications and transgene silencing by nickel chloride.

  2006cited by this paper
• Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.

  2006cited by this paper
• Chromatin control and cancer-drug discovery: realizing the promise.

  2006cited by this paper
• The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3

  2006influential reference
• Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols.

  2006cited by this paper
• Epigenetic control using natural products and synthetic molecules.

  2006influential reference
• Poly(ADP-ribose): novel functions for an old molecule

  2006cited by this paper
• The role of histone H3 phosphorylation (Ser10 and Ser28) in cell growth and cell transformation

  2006cited by this paper
• Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases.

  2006cited by this paper
• Histone ubiquitylation and the regulation of transcription.

  2006cited by this paper
• Epigenetics and human disease: translating basic biology into clinical applications

  2006cited by this paper
• Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

  2006cited by this paper
• The necessity of a human epigenome project.

  2006cited by this paper
• Targeting histone deacetylase in cancer therapy

  2006influential reference
• Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells.

  2006cited by this paper
• Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.

  2006influential reference
• Histone deacetylation is involved in activation of CXCL10 upon IFNgamma stimulation.

  2006cited by this paper
• The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment.

  2005cited by this paper
• Eukaryotic cytosine methyltransferases.

  2005cited by this paper
• Imprinting and looping: epigenetic marks control interactions between regulatory elements.

  2005cited by this paper
• Calorie restriction--the SIR2 connection.

  2005cited by this paper
• SIRT1 Regulates HIV Transcription via Tat Deacetylation

  2005cited by this paper
• Histone Deacetylases as Transcriptional Activators? Role Reversal in Inducible Gene Regulation

  2005cited by this paper
• Methylation of the guanidino group of arginine residues prevents citrullination by peptidylarginine deiminase IV

  2005cited by this paper
• Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

  2005influential reference
• DNA methylation and gene silencing in cancer

  2005cited by this paper
• Molecular Mechanisms of Epigenetics

  2005cited by this paper
• Small molecules: the missing link in the central dogma

  2005cited by this paper
• Mechanism of Aurora B activation by INCENP and inhibition by hesperadin.

  2005cited by this paper
• Poly(ADP-ribose)polymerase inhibition - where now?

  2005influential reference
• Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine

  2005cited by this paper
• The histone code at DNA breaks: a guide to repair?

  2005cited by this paper
• Something about SUMO inhibits transcription.

  2005cited by this paper
• PAD: the smoking gun behind arginine methylation signaling?

  2005cited by this paper
• LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription

  2005cited by this paper
• hDOT1L links histone methylation to leukemogenesis.

  2005cited by this paper
• Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP‐ribose) polymerase‐1/2 inhibitors

  2005cited by this paper
• Role of protein methylation in regulation of transcription.

  2005cited by this paper
• Histone deacetylase inhibitors: discovery and development as anticancer agents

  2005influential reference
• Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases.

  2005influential reference
• Histone Deacetylase Inhibitors in Programmed Cell Death and Cancer Therapy

  2005cited by this paper
• PRMT7, a New Protein Arginine Methyltransferase That Synthesizes Symmetric Dimethylarginine*

  2005cited by this paper
• In living color: DNA methyltransferase caught in the act

  2005influential reference
• Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9

  2005cited by this paper
• Poly(ADP-ribosyl)ation and Epigenetics: Is CTCF PARt of the Plot?

  2005cited by this paper
• Aberrant DNA methylation as a cancer-inducing mechanism.

  2005cited by this paper
• Defining the SUMO-modified Proteome by Multiple Approaches in Saccharomyces cerevisiae*

  2005cited by this paper
• Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes.

  2005cited by this paper
• Gene Expression Analysis of the Function of the Male-Specific Lethal Complex in Drosophila

  2005cited by this paper
• Progress in the development of selective inhibitors of Aurora kinases.

  2005cited by this paper
• Histone deacetylation in epigenetics: An attractive target for anticancer therapy

  2005cited by this paper

• Switching off the yeast-to-hyphae transition in Yarrowia lipolytica through histone deacetylase inhibitors.

  2025cites this paper
• Identification of novel anti-tumor peptides from enzymatic hydrolysis of soy-based tempeh and their mechanism in pancreatic and colorectal cancer cells

  2025cites this paper
• Design of a Bioluminescent Assay Platform for Quantitative Measurement of Histone Acetyltransferase Enzymatic Activity

  2024cites this paper
• The role of epigenetic mechanisms in the long-term effects of early-life adversity and mother-infant relationship on physiology and behavior of offspring in laboratory rats and mice.

  2024cites this paper
• Deciphering the Atlas of Post-Translational Modification in Sugarcane.

  2023cites this paper
• Protein modification by short-chain fatty acid metabolites in sepsis: a comprehensive review

  2023cites this paper
• Identification and Profiling of Histone Acetyltransferase Substrates by Bioorthogonal Labeling

  2022cites this paper
• Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis

  2022cites this paper
• Design, synthesis, and antitumor activity of PLGA nanoparticles incorporating a discovered benzimidazole derivative as EZH2 inhibitor.

  2021cites this paper
• Insights Into the Role of DNA Methylation in Immune Cell Development and Autoimmune Disease

  2021cites this paper
• Nutrients and phytonutrients as promising epigenetic nutraceuticals

  2021cites this paper
• Remodeling the Epigenetic Landscape of Cancer—Application Potential of Flavonoids in the Prevention and Treatment of Cancer

  2021cites this paper
• An Overview of Privileged Scaffold: Quinolines and Isoquinolines in Medicinal Chemistry as Anticancer Agents.

  2020cites this paper
• 表观遗传学在恶性肿瘤发生发展和治疗中的新进展

  2020cites this paper
• Large domains of heterochromatin direct the formation of short mitotic chromosome loops

  2020cites this paper
• Renin-angiotensin system and cancer: epidemiology, cell signaling, genetics and epigenetics

  2020cites this paper
• PRMT6 als mögliches Ziel einer Therapie und seine Wirkung in der Hämatopoese

  2019cites this paper
• Bisubstrate inhibitors to target histone acetyltransferase 1

  2019cites this paper
• Lysine methylation of transcription factors in cancer

  2019cites this paper
• Differential expression of tescalcin by modification of promoter methylation controls cell survival in gastric cancer cells.

  2019cites this paper
• Bioorthogonal Reporters for Detecting and Profiling Protein Acetylation and Acylation

  2019cites this paper
• A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy

  2018influential citation
• Chemical Biology Approaches for Investigating the Functions of Lysine Acetyltransferases.

  2018cites this paper
• اثرات ضد سرطانی سدیم بوتیرات بر روی رده سلولی Caco2 سرطان کولون انسانی

  2018cites this paper
• Dissecting the Molecular Basis of the Scaffold Protein JADE in HBO1 Histone Acetyltransferase (HAT) Activity

  2018cites this paper
• Untersuchung der epigenetischen Funktionen von Lysin‐Acetyltransferasen mit Methoden der chemischen Biologie

  2018cites this paper
• Anticancer effects of sodium butyrate on human colon cancer Caco2 cell line

  2018cites this paper
• Mechanisms and Inhibitors of Histone Arginine Methylation.

  2018cites this paper
• 3 Epigenetic Biomarkers in Bladder Cancer

  2017cites this paper
• Stress and the Emerging Roles of Chromatin Remodeling in Signal Integration and Stable Transmission of Reversible Phenotypes

  2017cites this paper
• Identification of novel EZH2 inhibitors through pharmacophore-based virtual screening and biological assays.

  2016cites this paper
• Natural Epigenetic-Modifying Molecules in Medical Therapy

  2016cites this paper
• Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1*

  2016cites this paper
• SAM/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases.

  2016cites this paper
• Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies.

  2016cites this paper
• Small Molecule Inhibitors of Protein Arginine Methyltransferases

  2016cites this paper
• Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles.

  2016cites this paper
• The State of the Art of Epigenetic Technologies

  2015cites this paper
• Effective Quenchers Are Required to Eliminate the Interference of Substrate: Cofactor Binding in the HAT Scintillation Proximity Assay

  2015cites this paper
• Exploration of Cyanine Compounds as Selective Inhibitors of Protein Arginine Methyltransferases: Synthesis and Biological Evaluation

  2015cites this paper
• From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?

  2015cites this paper
• Site Directed Mutagenesis , Expression and Enzymatic Studies of the 60 kDa Human HIV-TAT 1 Interactive Protein , TIP 60

  2015cites this paper
• Epigenetic therapy as a novel approach in hepatocellular carcinoma.

  2015cites this paper
• Histone Acetyltransferases: Enzymes, Assays, and Inhibitors

  2015cites this paper
• Microfluidic Engineering for Ultrasensitive Molecular Analysis of cells

  2015cites this paper
• Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1

  2014cites this paper
• Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells

  2014cites this paper
• Interaction between DNA/histone methyltransferases and their inhibitors.

  2014cites this paper
• Connecting Phytochemicals, Epigenetics, and Healthy Aging

  2014cites this paper
• Inflammation, advancing age and nutrition

  2014cites this paper
• Hepatocellular carcinoma DNA methylation Histone modifications Non-coding microRNAs Epigenetic therapy DNMT inhibitors HDAC inhibitors Natural products

  2014cites this paper
• Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells

  2014cites this paper
• Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein

  2014cites this paper
• Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?

  2013cites this paper
• Toxicogenomic approaches for understanding molecular mechanisms of heavy metal mutagenicity and carcinogenicity.

  2013cites this paper
• Modyfikacje epigenetyczne jako potencjalne cele terapii antynowotworowych

  2013cites this paper
• The fluorescence-based acetylation assay using thiol-sensitive probes.

  2013cites this paper
• Deciphering the language of histone crosstalk

  2013cites this paper
• Enzymatic Mechanisms and Chemical Probes of the Myst Family of Histone Acetyltransferases

  2013cites this paper
• Comparative studies of thiol-sensitive fluorogenic probes for HAT assays

  2013cites this paper
• Aberrant promoter CpG methylation and its translational applications in breast cancer

  2013cites this paper
• Methionine γ-Lyase 2-AminoButyrate Deaminase (MEGL-2ABD) as a Gene Therapeutic Agent for Cancers

  2013cites this paper
• Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes.

  2012cites this paper
• Kinetic mechanism and inhibitory study of protein arginine methyltransferase 1

  2012influential citation
• 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.

  2012cites this paper
• Novel functions of the MOZ double PHD finger domain

  2012cites this paper
• HEMD: An Integrated Tool of Human Epigenetic Enzymes and Chemical Modulators for Therapeutics

  2012cites this paper
• Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents.

  2012cites this paper
• Epigenetic Biomarkers in Bladder Cancer

  2012cites this paper
• Chemical and biochemical approaches in the study of histone methylation and demethylation

  2012cites this paper
• Protein arginine methyltransferases (PRMTs) as therapeutic targets

  2012cites this paper
• Environmental chemical exposures and human epigenetics.

  2012cites this paper
• Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation.

  2012cites this paper
• Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis.

  2012cites this paper
• High-throughput strategy to identify inhibitors of histone-binding domains.

  2012cites this paper
• Genome-wide DNA methylation profiling of CpG islands in hypospadias.

  2012cites this paper
• Identification of small-molecule enhancers of arginine methylation catalyzed by coactivator-associated arginine methyltransferase 1.

  2012cites this paper
• New cytosine derivatives as inhibitors of DNA methylation.

  2012cites this paper
• Function of the Active Site Lysine Autoacetylation in Tip60 Catalysis

  2012cites this paper
• Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition.

  2012cites this paper
• Synthesis and bioactivity of novel histone acetylation inhibitors: potential new drugs for treatment of cancer and inflammation

  2011cites this paper
• Effects of epigenetic‐based anti‐cancer drugs in leukaemia and multiple myeloma cells

  2011cites this paper
• Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma

  2011cites this paper
• Clinical Relevance of Circulating Nucleic Acids in Blood of Prostate Cancer Patients

  2011cites this paper
• Nuclear protein isoforms: Implications for cancer diagnosis and therapy

  2011cites this paper
• Small molecule inhibitors of histone acetyltransferase Tip60.

  2011cites this paper
• Epigenetics, Nutrition, and Cancer

  2011cites this paper
• Development of Inhibitors and Assay Methods for Histone Acetyltransferases

  2011cites this paper
• Influência do bloqueio do receptor do peptídeo liberador de gastrina em combinação com inibição de histona deacetilase sobre a proliferação de células de neuroblastoma

  2011cites this paper
• Genome-Wide Integration on Transcription Factors, Histone Acetylation and Gene Expression Reveals Genes Co-Regulated by Histone Modification Patterns

  2011cites this paper
• Phytochemicals and Cancer Chemoprevention: Epigenetic Friends or Foe?

  2011cites this paper
• Histone H4 Acetylation Differentially Modulates Arginine Methylation by an in Cis Mechanism*

  2011cites this paper
• De-mystifying the epigenetic free for all : pharmacophore modeling for epigenetic cancer therapy

  2011cites this paper
• Synthesis and bioactivity of novel histone acetylation inhibitors

  2011cites this paper
• Lunasin: A Novel Seed Peptide with Cancer Preventive Properties

  2011cites this paper
• Epigenetics and Cancer:Target Epigenetic Alterations in Tumor

  2011cites this paper
• EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo

  2011cites this paper
• Cell-free nucleic acids as biomarkers in cancer patients

  2011cites this paper
• Oncoproteomics.

  2011cites this paper
• Targets in Epigenetics: Inhibiting the Methyl Writers of the Histone Code

  2011cites this paper